Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX)

CAPS Rating: 2 out of 5

A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction.

Recs

0
Player Avatar pchop123 (76.55) Submitted: 9/26/2012 9:38:04 PM : Outperform Start Price: $1.62 CPRX Score: +4.50

Green Flag this one

Featured Broker Partners


Advertisement